ANDA Approvals – Winter 2024

Start
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA….
By: Robins Kaplan LLP
Previous Story

Catholic Charities of Southern Nevada Reports Data Breach Affecting the Personal Info of 73,822 People

Next Story

VectraRx Mail Pharmacy Sends Out Data Breach Letters Following December 2024 Cyberattack